Arkolith/Insider Trading/STSA/Form 4

Commodore Capital LP

10% OwnerSatsuma Pharmaceuticals, Inc. (STSA) · full profile →Form 4 · filed Nov 16, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2022Sell(S)3.3M$0.71$2.3M461K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-032622) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML